Abstract
Ovarian cancer (OC), a common gynecological malignancy, seriously threatens the lives and health of women. Though several serological markers are used for the early diagnosis of OC, most have low specificity and sensitivity. Micro-RNAs (miRNAs), a family of non-coding RNAs that function at the post-transcriptional level, are emerging as specific biomarkers to achieve effective diagnosis and treatment strategies for OC. In this review, we summarize the current investigations on miRNAs in the detection and monitoring of OC and discuss the molecular mechanisms that may provide a reliable detection method for OC at early stages. Thus, miRNAs are promising biomarkers, suggesting their potential as therapeutic targets in OC.